LIVN
VENTE TOTALE: 3 950 titres (~318 808,14 $ US)
- Insiders
- Story Brooke, Bianchi Francesco
- Total bought
- —
- Total sold
- $318,808
- Last activity
- 2026-09-04
- Last synced
-
2026-09-10 10:26:50
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-10
LIVN presents a mixed profile: a genuine earnings catalyst (Q2 2026 beat + raised outlook) with moderate confidence (0.65) is partially offset by deteriorating fundamentals, including a return to net losses, negative…
The first sentence of the analysis written for LIVN on 2026-09-10 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 67.7% | 69.5% | 66.9% | 69.2% | 68.2% | |
| Ebit Margin | -12.4% | 12.1% | -1.9% | -2.6% | -7.2% | |
| Ebitda Margin | -9.3% | 16.2% | 3.3% | 3.0% | -0.6% | |
| Operating Profit Margin | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% | |
| Pretax Profit Margin | -15.9% | 7.0% | -7.1% | -7.4% | -12.0% | |
| Continuous Operations Profit Margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | |
| Net Profit Margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | |
| Bottom Line Profit Margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | |
| Current Ratio | 1.363 | 2.875 | 2.950 | 2.980 | 0.974 | |
| Quick Ratio | 1.159 | 2.498 | 2.508 | 2.545 | 0.823 | |
| Solvency Ratio | -0.143 | 0.096 | 0.068 | -0.026 | -0.075 | |
| Cash Ratio | 0.787 | 1.094 | 0.796 | 0.720 | 0.298 | |
| Price To Earnings Ratio | -13.827 | 39.581 | 156.788 | -34.497 | -32.623 | |
| Price To Earnings Growth Ratio | 0.029 | 0.155 | -1.301 | 0.864 | 0.526 | |
| Forward Price To Earnings Growth Ratio | 0.029 | 0.155 | -1.301 | 0.864 | 0.526 | |
| Price To Earnings Diluted Ratio | -13.827 | 39.922 | 161.688 | -34.497 | -32.623 | |
| Price To Earnings Diluted Growth Ratio | 0.029 | 0.152 | -1.349 | 0.864 | 0.526 | |
| Price To Book Ratio | 2.794 | 1.903 | 2.183 | 2.461 | 3.419 | |
| Price To Sales Ratio | 2.416 | 2.004 | 2.418 | 2.908 | 4.276 | |
| Price To Free Cash Flow Ratio | 19.361 | 18.479 | 69.837 | 68.465 | 57.442 | |
| Price To Operating Cash Flow Ratio | 13.187 | 13.723 | 37.226 | 42.509 | 43.170 | |
| Debt To Assets Ratio | 0.182 | 0.270 | 0.264 | 0.253 | 0.130 | |
| Debt To Equity Ratio | 0.394 | 0.513 | 0.501 | 0.481 | 0.221 | |
| Debt To Capital Ratio | 0.283 | 0.339 | 0.334 | 0.325 | 0.181 | |
| Long Term Debt To Capital Ratio | 0.247 | 0.294 | 0.308 | 0.300 | 0.008 | |
| Financial Leverage Ratio | 2.172 | 1.898 | 1.902 | 1.900 | 1.700 | |
| Working Capital Turnover Ratio | 2.699 | 1.806 | 1.858 | 3.579 | 5.432 | |
| Operating Cash Flow Ratio | 0.315 | 0.467 | 0.224 | 0.235 | 0.147 | |
| Operating Cash Flow Sales Ratio | 0.183 | 0.146 | 0.065 | 0.068 | 0.099 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.681 | 0.743 | 0.533 | 0.621 | 0.752 | |
| Debt Service Coverage Ratio | -1.870 | 1.258 | 1.785 | 0.277 | -0.063 | |
| Interest Coverage Ratio | 4.046 | 2.046 | -1.164 | -1.591 | -0.016 | |
| Short Term Operating Cash Flow Coverage Ratio | 8.073 | 2.347 | 4.136 | 2.983 | 0.446 | |
| Operating Cash Flow Coverage Ratio | 0.537 | 0.270 | 0.117 | 0.120 | 0.358 | |
| Capital Expenditure Coverage Ratio | 3.136 | 3.886 | 2.142 | 2.638 | 4.025 | |
| Dividend Paid And Capex Coverage Ratio | 3.136 | 3.886 | 2.142 | 2.638 | 4.025 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -24.642 | 13.627 | 82.184 | 108.000 | -711.441 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 67.7% | ▼-1.8% | ▼-0.6% |
| Ebit Margin | -12.4% | ▼-24.4% | ▼-10.0% |
| Ebitda Margin | -9.3% | ▼-25.5% | ▼-11.8% |
| Operating Profit Margin | 14.4% | ▲4.1% | ▲12.1% |
| Pretax Profit Margin | -15.9% | ▼-22.9% | ▼-8.8% |
| Continuous Operations Profit Margin | -17.5% | ▼-22.5% | ▼-11.0% |
| Net Profit Margin | -17.5% | ▼-22.5% | ▼-11.0% |
| Bottom Line Profit Margin | -17.5% | ▼-22.5% | ▼-11.0% |
| Current Ratio | 1.363 | ▼-1.511 | ▼-0.865 |
| Quick Ratio | 1.159 | ▼-1.339 | ▼-0.747 |
| Solvency Ratio | -0.143 | ▼-0.239 | ▼-0.127 |
| Cash Ratio | 0.786 | ▼-0.307 | ▲0.048 |
| Price To Earnings Ratio | -13.827 | ▼-53.408 | ▼-36.911 |
| Price To Earnings Growth Ratio | 0.029 | ▼-0.127 | ▼-0.026 |
| Forward Price To Earnings Growth Ratio | 0.029 | ▼-0.127 | ▼-0.026 |
| Price To Earnings Diluted Ratio | -13.827 | ▼-53.749 | ▼-37.960 |
| Price To Earnings Diluted Growth Ratio | 0.029 | ▼-0.123 | ▼-0.016 |
| Price To Book Ratio | 2.795 | ▲0.892 | ▲0.242 |
| Price To Sales Ratio | 2.416 | ▲0.412 | ▼-0.388 |
| Price To Free Cash Flow Ratio | 19.361 | ▲0.882 | ▼-27.355 |
| Price To Operating Cash Flow Ratio | 13.187 | ▼-0.536 | ▼-16.776 |
| Debt To Assets Ratio | 0.182 | ▼-0.088 | ▼-0.038 |
| Debt To Equity Ratio | 0.394 | ▼-0.118 | ▼-0.028 |
| Debt To Capital Ratio | 0.283 | ▼-0.056 | ▼-0.009 |
| Long Term Debt To Capital Ratio | 0.247 | ▼-0.047 | ▲0.016 |
| Financial Leverage Ratio | 2.172 | ▲0.273 | ▲0.257 |
| Working Capital Turnover Ratio | 2.699 | ▲0.893 | ▼-0.376 |
| Operating Cash Flow Ratio | 0.315 | ▼-0.152 | ▲0.037 |
| Operating Cash Flow Sales Ratio | 0.183 | ▲0.037 | ▲0.071 |
| Free Cash Flow Operating Cash Flow Ratio | 0.681 | ▼-0.062 | ▲0.015 |
| Debt Service Coverage Ratio | -1.870 | ▼-3.128 | ▼-2.148 |
| Interest Coverage Ratio | 4.046 | ▲2.000 | ▲3.381 |
| Short Term Operating Cash Flow Coverage Ratio | 8.073 | ▲5.726 | ▲4.476 |
| Operating Cash Flow Coverage Ratio | 0.537 | ▲0.267 | ▲0.257 |
| Capital Expenditure Coverage Ratio | 3.136 | ▼-0.750 | ▼-0.029 |
| Dividend Paid And Capex Coverage Ratio | 3.136 | ▼-0.750 | ▼-0.029 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -24.642 | ▼-38.269 | ▲81.813 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.35B | $2.51B | $2.79B | $2.97B | $4.43B | |
| Enterprise value | $3.19B | $2.76B | $3.16B | $3.34B | $4.51B | |
| EV / Sales | 2.30x | 2.20x | 2.74x | 3.27x | 4.35x | |
| EV / Op. cash flow | 12.55x | 15.08x | 42.22x | 47.75x | 43.94x | |
| EV / Free cash flow | 18.42x | 20.30x | 79.20x | 76.90x | 58.46x | |
| EV / EBITDA | -24.64x | 13.63x | 82.18x | 108.00x | -711.44x | |
| Net debt / EBITDA | 1.25x | 1.22x | 9.72x | 11.85x | -12.43x | |
| Current ratio | 1.36x | 2.88x | 2.95x | 2.98x | 0.97x | |
| Income quality | -1.05x | 2.90x | 4.27x | -0.81x | -0.76x | |
| Graham number | — | $25 | $13 | — | — | |
| Graham net-net | -$10 | -$10 | -$12 | -$12 | -$9 | |
| Tax burden | 109.8% | 71.6% | -21.6% | 114.7% | 109.0% | |
| Interest burden | 128.7% | 58.3% | 363.5% | 279.6% | 167.7% | |
| Working capital | $293.5M | $735.1M | $653.2M | $588.7M | -$17.8M | |
| Invested capital | $1.61B | $1.94B | $1.90B | $1.91B | $1.47B | |
| Return on assets | -9.3% | 2.5% | 0.7% | -3.8% | -6.2% | |
| Operating ROA | 7.8% | 5.2% | -2.9% | -3.4% | -0.0% | |
| Return on tangible assets | -15.3% | 4.2% | 1.3% | -7.5% | -15.1% | |
| Return on equity | -20.2% | 4.8% | 1.4% | -7.1% | -10.5% | |
| Return on invested capital | 10.9% | 4.2% | 0.7% | -3.8% | -0.0% | |
| Return on capital employed | 11.1% | 6.1% | -3.3% | -3.8% | -0.1% | |
| Earnings yield | -7.2% | 2.5% | 0.6% | -2.9% | -3.1% | |
| Free cash flow yield | 5.2% | 5.4% | 1.4% | 1.5% | 1.7% | |
| Capex / Op. cash flow | 31.9% | 25.7% | 46.7% | 37.9% | 24.8% | |
| Capex / Depreciation | 193.1% | 92.1% | 57.5% | 45.8% | 37.5% | |
| Capex / Sales | 5.8% | 3.8% | 3.0% | 2.6% | 2.5% | |
| SG&A / Sales | 39.5% | 42.0% | 44.9% | 45.9% | 45.6% | |
| R&D / Sales | 13.4% | 14.6% | 16.8% | 15.2% | 17.7% | |
| Stock comp / Sales | 2.6% | 2.7% | 3.2% | 4.4% | 3.9% | |
| Intangibles / Total assets | 39.2% | 39.4% | 43.0% | 49.6% | 59.0% | |
| Days sales outstanding | 57d | 65d | 68d | 77d | 79d | |
| Days payables outstanding | 79d | 67d | 77d | 86d | 75d | |
| Operating cycle | 191d | 206d | 209d | 227d | 196d | |
| Cash conversion cycle | 112d | 139d | 132d | 141d | 121d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+33.5%EV / Sales ▲+4.4%EV / EBITDA ▼-280.8%EV / Op. cash flow ▼-2.529Earnings yield ▼-0.097
Profitability
Return on equity ▼-0.250Return on assets ▼-0.118Return on invested capital ▲+0.067Return on capital employed ▲+0.050Operating ROA ▲+0.026Income quality ▼-3.943Tax burden ▲+0.382
Efficiency
Days sales outstanding ▼-8.345Days payables outstanding ▲+12.632Operating cycle ▼-15.009Cash conversion cycle ▼-27.641Capex / Sales ▲+0.021R&D / Sales ▼-0.012
Balance-sheet strength
Current ratio ▼-1.511Net debt / EBITDA ▲+0.029Working capital ▼-441561000.000Invested capital ▼-325058000.000Intangibles / Total assets ▼-0.001
Change over 5 years
Valuation
Market cap ▼-24.2%EV / Sales ▼-47.2%EV / EBITDA ▲+96.5%EV / Op. cash flow ▼-31.389Earnings yield ▼-0.042
Profitability
Return on equity ▼-0.097Return on assets ▼-0.031Return on invested capital ▲+0.109Return on capital employed ▲+0.111Operating ROA ▲+0.078Income quality ▼-0.294Tax burden ▲+0.008
Efficiency
Days sales outstanding ▼-21.809Days payables outstanding ▲+3.801Operating cycle ▼-4.971Cash conversion cycle ▼-8.772Capex / Sales ▲+0.034R&D / Sales ▼-0.043
Balance-sheet strength
Current ratio ▲+0.389Net debt / EBITDA ▲+13.682Working capital ▲+311289000.000Invested capital ▲+142316000.000Intangibles / Total assets ▼-0.198
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-15 LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE Bank of America Corp DE cut its holdings in shares of LivaNova PLC (NASDAQ: LIVN) by 30.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 533,017 shares of the company''s stock after selling 235,233 shares during the quarter. Bank of America Corp
- 2026-08-10 Dynatronics (NASDAQ:DYNT) vs. LivaNova (NASDAQ:LIVN) Critical Review LivaNova (NASDAQ: LIVN - Get Free Report) and Dynatronics (NASDAQ: DYNT - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Risk and Volatility LivaNova has a beta of 0.86, indicating
- 2026-08-06 LivaNova Q2 Earnings & Revenues Beat Estimates, ''26 Outlook Raised LIVN''s Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.
- 2026-08-05 LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript
- 2026-08-05 LivaNova Q2 Earnings Call Highlights LivaNova NASDAQ: LIVN reported record quarterly revenue and adjusted earnings per share for the second quarter of 2026, citing double-digit reported growth across its Cardiopulmonary and Epilepsy businesses. The company raised its full-year revenue and adjusted EPS outlook while reducing its adjusted free-cash-flow forecast to account for increased investment in manufacturing capacity, innovation and IT infrastructure.
- 2026-08-05 LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for LivaNova (LIVN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 2026-08-05 LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run? LivaNova (LIVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company''s fundamentals for clues.
- 2026-08-05 LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates LivaNova (LIVN) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.05 per share a year ago.
- 2026-08-05 LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance GLOUCESTER, England--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the second quarter ended June 30, 2026 and raised full-year 2026 guidance. Financial Summary and Highlights(1) Second-quarter revenue of $390.6 million increased 10.8% on a reported basis and 9.8% on a constant-currency basis as compared to the prior-year period Second-quarter U.S. GAAP diluted earnings per share of $1.93 and adjusted diluted earnings per sh.
- 2026-08-05 Amundi Cuts Stock Position in LivaNova PLC $LIVN Amundi cut its position in shares of LivaNova PLC (NASDAQ: LIVN) by 3.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 172,784 shares of the company''s stock after selling 6,304 shares during the quarter. Amundi owned approximately 0.31% of LivaNova worth